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a Saudi ArabiaBackground and objectives: Sickle cell disease (SCD) is a chronic, inherited haemoglobin disorder, associated with
recurrent vaso-occlusive and haemolytic crises and chronic tissue ischemia which may adversely affect any organ
system. Our objectives were to evaluate the left ventricular (LV) systolic and diastolic functions in Saudi patients with
SCD originally from the Eastern Province of Saudi Arabia.
Design and setting: Prospective hospital based echocardiography study on adolescent and adult patients with
SCD.
Methods: Forty-five patients with SCD were recruited for echocardiographic study while 45 patients, matched for
age and sex, served as controls. Left and right ventricular dimensions and LV wall thicknesses, LV mass index
(LVMI) and LV contractility variables were obtained. Left atrial dimension and volume and pulmonary artery sys-
tolic pressure (PASP) were also estimated. We also evaluated parameters of LV diastolic function, including early
and late mitral flow velocities (E and A wave respectively), E/A ratio, deceleration time (MVDT), A wave duration
(MVA D), LV isovolumic relaxation time (IVRT), and tissue Doppler velocities, such as lateral annular e‘ wave, a‘
wave, e‘/a‘ ratio and E/e‘ ratio.
Results: There were increases in the LV dimensions, LV volumes, stroke volume, and LVMI of the SCD patients.
The preload was increased (LV diastolic volume) and afterload was decreased (low diastolic blood pressure). The
LVEF was equivalent, though there was evidence of LV diastolic dysfunction in 24%, and pulmonary hypertension
(PH) in 40% of the SCD patients. The mean left atrial volume (LAV) was also increased in the SCD patients.
Conclusion: LV diastolic dysfunction (heart failure with preserved ejection fraction) and PH may complicate cases
of the Arab-Indian haplotype of SCD.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Abbreviations: MVE vel,mitral valve flow E wave velocity (cm. sec), MVA vel,mitral valve flow A wave velocity (cm.
sec), E/A, E wave/A wave ratio, MVDT, mitral valve deceleration time (ms), MVAD, mitral valve A wave duration
(ms), TDI, tissue doppler imaging, Lat e‘, lateral annular e‘ wave velocity by TDI (cm. sec), Lat a‘, lateral annular a‘
wave velocity by TDI (cm. sec), e‘/a‘, e‘ wave/a‘ wave ratio, E/e‘, mitral flow E wave velocity/lateral annular e‘ wave
velocity by TDI
Keywords: Sickle cell disease, Left ventricular diastolic function, Left ventricular systolic function, Tissue doppler
imagingProduction and hosting by Elsevier
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The assessment of LV diastolic function shouldbe an integral part of a routine echocardio-
graphic examination, particularly in patients pre-
senting with dyspnea or heart failure. About half
of the patients with a new diagnosis of heart fail-
ure have normal or near normal global left ven-
tricular ejection fraction (LVEF). These patients
are diagnosed with ‘‘diastolic heart failure’’ or
‘‘Heart Failure with Preserved Ejection Fraction –
HFPEF’’ [1].
Sickle cell disease (SCD) is an important autoso-
mal recessive haemoglobin disorder characterized
by recurrent episodes of haemolytic and vaso-
occlusive crises due to entrapment of red blood
corpuscles in the microvasculature leading to
ischemia–reperfusion injury and infarction in
multiple organ systems. The poorly controlled
lifelong hemolytic anemia and recurrent episodes
of organ infarction ultimately lead to a progressive
systemic vasculopathy and chronic organ failure
[2]. The prevalence of homozygous SCD (HbSS)
ranges from 1.2% to 2.6% in the Eastern Province
of Saudi Arabia [3–6]. Structural studies of DNA
suggest that the sickle cell mutation in the Eastern
Province of Saudi Arabia and India has arisen as a
separate and independent mutation compared
with the four different occasions of mutation that
took occurred in Africa [7–11]. The prevalence of
cardiac involvement in African American adult
patients with SCD is up to 82%, ranging from car-
diomegaly to congestive heart failure (CHF)] [12–
14]. Diastolic dysfunction, as an early marker of
cardiac involvement, precedes the development
of CHF and is frequently found in paediatric pa-
tients with SCD [12–14]. Nonetheless, diastolic
dysfunction and pulmonary hypertension both
contribute independently to prospective mortality
in patients with SCD. Patients with both risk fac-
tors have an extremely poor prognosis [15]. It is
believed that patients suffering from SCD in the
Eastern Province of Saudi Arabia have a milder
form of the disease with less frequent complica-
tions and a good outcome, due to the interaction
between thalassemia and SCD, and the presence
of the Arab-Indian haplotype [16]. However, an
epidemiological study has shown that the clinical
presentation and complications of SCD in Saudi
Arabia varies significantly [17]. Unfortunately,
only a single report about the cardiovascular man-
ifestation of SCD [18] was found but there was no
reported study evaluating left ventricular diastolic
function in Saudi patients with SCD. Thus, the
main objective of this prospective study was to
evaluate the cardiac performance in general,concentrating particularly on left ventricular dia-
stolic function parameters using Tissue Doppler
Imaging (TDI) in adolescents and adult patients
with SCD whose origins are in the Eastern prov-
ince of Saudi Arabia.Subjects and methods
SCD and control patients were recruited after
obtaining informed consent from each patient be-
tween January 1st 2010 and July 31st 2011. The
SCD group consisted of 45 adolescents and young
adults (17–40 years) who were originally from the
Eastern Province of Saudi Arabia, and who had
been followed in the Haematology Clinic at King
Fahd Hospital of the University (KFHU), Al-Kho-
bar. Also recruited were inpatients admitted to
the medical wards of the same hospital after com-
plete resolution of all the clinical features of acute
sickle cell crises. The study protocol conforms to
the ethical guidelines of the 1975 Declaration of
Helsinki as reflected in priori approval by the insti-
tution’s human research committee. The pulse
oxy-meter showed normal oxygen saturation for
every recruited SCD patient. Patient’s charts were
reviewed and patients’ demographic, clinical and
laboratory data were obtained. Patients with SS
hemoglobin disease underwent a detailed trans-
thoracic echocardiographic and echo-Doppler
evaluation while in a clinical stable state. Patients
were excluded from this study if they were on
chronic transfusion therapy or if they have re-
ceived recent blood transfusion, had hemoglobin-
opathies other than SCD, had known congenital
or acquired cardiac or pulmonary diseases, elec-
trocardiographic abnormalities which may affect
the interpretation of the echocardiographic find-
ings, or had any medical conditions other than
anemia affecting their myocardial performance.
Subjects with inadequate acoustic windows were
also excluded. The control group consisted of 45
age- and sex matched subjects referred to the
echocardiography laboratory with diagnoses of
heart murmur, palpitations, or syncope, and
found to have normal echocardiograms.
Clinical data
Blood pressure measurements were performed
prior to the echocardiogram. Mean hemoglobin
(Hb), hemoglobin F (Hb F), and ferritin levels for
1 year preceding the study were calculated.
Echocardiographic examination
All studies were performed using a Diagnostic
Ultrasound System, Xario Prime Ultrasound from
Figure 1. Lateral mitral annular TDI of a SCD patient showing LV diastolic dysfunction (e‘/a‘ ratio of 0.79) in one of the study patients.
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equipped with tissue Doppler imaging (TDI)
technology. All subjects underwent a complete
two-dimensional, spectral Doppler, color Doppler
flow, and TDI examination. Echocardiograms
were recorded digitally and subsequently ana-
lyzed by the use of a digital analysis system
(Phillips Xcelera R2.2L.1.SP2; 2.2.1258–2009).
M-Mode measurements
The left ventricular mass (LVM) was calculated
using the ASE-cube method in Devereux modifi-
cation guided by parasternal short axis view [19]
and was normalized for the body surface area
(BSA) to estimate the left ventricular mass index
(LVMI). Systolic function was considered abnor-
mal if the fraction of shortening was less than
28% or LVEF was less than 50%. Pulmonary artery
systolic pressure (PASP) was calculated by adding
an assumed right atrial pressure of 10 mm Hg to
the regurgitant jet gradient across the tricuspid
valve. Pulmonary artery systolic hypertension
was defined as PASP > 30 mm Hg [20].
Mitral flow velocity measurements
Transmitral Doppler flow signals were recorded
in the apical four-chamber view as described by
Rakowski et al.[1,21] Three measurements of each
index were performed and averaged for data anal-
ysis. Peak mitral flow velocities in early diastole(E) and during atrial contraction (A) were mea-
sured. The early/late velocity ratio (E/A) was cal-
culated. Measurement of left atrial volume: LAV
was measured by Simpson’s method in apical four
and two- chamber views and the average was in-
dexed to body surface area (BSA). Timing of the
measurement was defined at maximal expansion
of the left atrium.
Measurements of myocardial TDI velocities
TDI myocardial velocities were measured in the
longitudinal axis from the apical four-chamber
view. Myocardial velocities were sampled at the
level of the mitral annulus on the lateral aspects
as shown in Fig. 1 [1]. The spectral pulsed Doppler
studies were recorded digitally. The peak veloci-
ties during early diastole (e‘), and late diastole
(a‘) were measured and averaged over five con-
secutive beats. The early mitral inflow/annular
movement ratios (E/e‘) was also calculated [22].
Statistical analysis
Results were expressed as mean ± SD. Each of
the variables and ratios in the two studied groups
were compared using 2-sample t-tests. The Spear-
man coefficients were used to measure correlation
between various patient (demographic and clini-
cal) characteristics and patient outcomes univari-
ately. In a multivariate analysis, stepwise linear
regression analysis was performed to explore
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For this analysis, Left Ventricular IVRT, left atrial
volume index (LAVI), E wave velocity, A wave
velocity, E/A ratio, MV dec. time, MVA wave
Dur, PASP, lateral annular e‘, lateral a‘, e‘/a‘ ratio,
and E/e‘ ratio were chosen as diastolic outcome
variables. A P value of <0.05 was considered statis-
tically significant for all comparisons.Results
The demographic and laboratory characteristics
of the 45 SCD patients and 45 control subjects are
shown in Table 1. The mean (SD) heart rate (HR)
was significantly higher in SCD patients than in
controls, the mean (SD) systolic blood pressure
(SBP) was similar in both groups [119.56 (13.25)
mmHg in SCD patients and 120.9 (8.83) mmHg,
p = 0.712 in controls], whereas, the mean (SD) dia-
stolic blood pressure (DBP) was significantly lower
in SCD patients than in controls [69.31 (6.98)
mmHg vs.78.67 (4.3) mmHg, P = 0.003]. The means
(SD) of body weight, height, and BSA and hemo-
globin% were significantly lower in SCD patients
than in controls, but the mean (SD) ferritin level
was much higher in SCD patients than in controls.
The means (SD) of LV internal dimensions in dias-
tole and systole (LVIDd and LVIDS), LV end dia-
stolic and end systolic volumes (EDV and ESV),
stroke volumes (SV), inter-ventricular septum
thickness (IVST), LV posterior wall thickness
(LVPWT), and LV mass indexes (LVMI) were sig-
nificantly increased in SCD patients than in con-
trols, as shown in Table 2 and Fig. 2
[LVIDd = 5.34 (0.41) cm in SCD patients vs. 4.74
(0.46) cm in controls, p < 0.001, LVIDs = 3.38 (0.37)
cm vs. 3 (0.29) cm, p < 0.001, EDV = 139.9 (27.4)
ml vs. 108.4 (18.9) ml, p < 0.001, ESV = 47.2 (14.7)
ml vs. 36.3 (8.3) ml, p < 0.001, SV = 92.5 (21.4) ml
vs. 72.1 (13.6) ml, p < 0.001, IVST = 0.95 (0.12) cm
vs. 0.86 (0.15) cm, p = 0.004, LVPWT = 0.94 (0.14)
cm vs. 0.87(0.12) cm, p = 0.008, and LVMI = 122.5Table 1. Clinical characteristics of Sickle Cell Disease Patients ver
Variable SCD N = 45 mean (SD)
Age (years) 25.73 (6.79)
Male gender (%) 82
HR (bpm) 63.53 (6.15)
Systolic BP (mmHg) 120.9 (8.83)
Diastolic BP (mmHg) 78. 67 (4.3)
Weight (kg) 69.36 (10.07)
Height (cm) 167.64 (6.79)
BSA (m2) 1.77 (0.14)
Hb (gm/dl) 14.36 (0.97)
Ferritin level (mcg/l) 123.8 (64.62)(27.2) g/m2 vs. 81.7 (19.3) g/m2, p = 0.001], although
LV systolic function didn’t change [average
LVEF = 65.8% (6.6) in SCD patients vs. 67% (5.1)
in controls, p = 0.313].Frequency of LV diastolic dysfunction in SCD
patients
There was no significant difference between the
2 groups regarding the means (SD) of IVRT,
MVDT, MVAD and mitral inflow E/A ratio
[IVRT = 66.2 (18.3) msec. in SCD patients vs. 62.7
(23.6) msec. in controls, p = 0.431, MVDT = 197.7
(48.3) msec. vs. 203 (50.96) msec. p = 0.591,
MVAD = 124.9 (32.7) msec. vs.126 (30.8)) msec.
p = 0.763 and E/A = 1.66 (0.54) vs. 1.79 (0.69),
p = 0.330] as shown in Table 2. However, there
were highly significant differences between the 2
groups in the mean of left atrium volume indexes
(LAVI), mean (SD) of lateral mitral annular e‘
waves, lateral mitral annular a‘ waves and e‘/a‘ ra-
tio obtained by TDI and E/e‘ ratio [LAVI = 41.16 ml
in SCD vs. 22.65 ml in controls, p < 0.001, Lat.
e‘ = 13.5 (2.74) cm/s. vs. 16.13 (3.91) cm/s.
p < 0.001, Lat. a‘ = 10.7 (3.9) cm/s vs. 8.2 (2) cm/s,
p < 0.001, e‘/a‘ = 1.4 (0.4) vs. 2.1 (0.59), p < 0.001,
and the E/e‘ = 7.3 (1.6) vs. 5.9 (1.5), p < 0.001] as
shown in Table 2 and Fig. 2. We found also that
24% of the SCD patients had an e‘/a‘ ratio <1 as
an evidence of left ventricular diastolic dysfunc-
tion, and a moderate increase in E/e‘ ratio (be-
tween 8 and 15) in 24% of SCD patients which
may be considered as a reasonable predictor of in-
creased LV filling pressure as shown in Table 3 and
Fig. 2. This increase in the mitral inflow E/e‘ ratio
was powered by the elevated PASP of >30 mmHg
in 18 (40%) of SCD patients as shown in Fig. 3
[mean (SD) PASP of 35.6 (12.09) mmHg in SCD
patients vs. 20.08 (3.08) mmHg in controls,
p < 0.001] and the significantly increased mean
LA volume indexes. Of our SCD patients with
PH, only five (11.1%) were found to have decreased
lateral annular e‘/a‘ ratio <1, and 8 (17.7%) weresus Normal Control.
Normal control N = 45 mean (SD) P value
27.58 (9.67) 0.291
84 0.293
80.89 (8.23) <0.001
119.56 (13.25) =0.712
69.31 (6.98) =0.003
53.16 (11.68) <0.001
163.02 (5.33) <0.001
1.54 (0.170 <0.001
8.60 (1.14) <0.001
919.4 (1315) =0.006
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Table 2. Echocardiographic and echo-doppler parameters of sickle cell disease patients versus controls.
Echo/doppler variables SCD patients N = 45 mean (SD) Controls N = 45 mean (SD) P value
(A) LV structure, volumes and systolic function
LVIDd (cm) 5.34 (0.41) 4.74 (0.46) <0.001
LVIDs (cm) 3.38 (0.37)) 3 (0.29) <0.001
IVST (cm) 0.95 (0.12) 0.86 (0.15) =0.004
LVPWT (cm) 0.94 (0.14) 0.87 (0.12) =0.008
EDV (ml) 139.9 (27.4) 108.4 (18.9) <0.001
ESV (ml) 47.2 (14.7) 36.3 (8.3) <0.001
SV (ml) 92.5 (21.4) 72.1 (13.6) <0.001
LVM. I (g/m2) 122.5 (27.2) 81.7 (19.3) <0.001
LV. EF (%) 65.8 (6.6) 67 (5.1) =0.313
(B) LV diastolic function
LV. IVRT (ms) 66.2 (18.3) 62.7 (23.6) =0.431
LAV (ml) 63.38 (19.23) 40.09 (4.37) <0.001
LAVI (ml) 41.16 22.65 <0.001
E/A 1.66 (0.54) 1.79 (0.69) =0.330
MV Dec. Time (ms) 197.7(48.3) 203 (50.96) =0.591
MV. A Dur. (ms) 124.9 (32.7) 126 (30.8) =0.763
Lat. e‘ (cm/s) 13.5 (2.74) 16.13 (3.91) <0.001
Lat. a‘ (cm/s) 10.7 (3.9) 8.2 (2) <0.001
e‘/a‘ 1.4 (0.4) 2.1 (0.59) <0.001
E/e‘ 7.3 (1.6) 5.9 (1.5) <0.001
(C) Estimated mean PASP 35.6 (12.09) 20 (3.08) <0.001
Table 3. Patients with TDI evidence of LV diastolic dysfunction
and patients with combined LV diastolic dysfunction param-
eters and pulmonary hypertension (PH).
LV diastolic dysfunction SCD
n = 45
n %
e‘/a‘ < 1 11 24
E/e‘ > 8 11 24
e‘/a‘ < 1 + PH 5 11.1
E/e‘ > 8 + PH 8 17.7
J Saudi Heart Assoc
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15) as shown in Table 3 and Fig. 4. Nonetheless,
mild mitral regurgitation without structural dam-
age of mitral valve was found in 18 SCD patients
(40%) versus 8 (18%) of controls, p = 0.002. Using
stepwise linear regression analysis, 58.4% of body
surface areas (BSA) of SCD patients were ex-
plained by ESV, SV, IVRT, LAV, PASP, Lateral
annular e‘, lateral annular a‘ and E/e‘. Similarly
54.7% of hemoglobin concentrations in SCD pa-
tients were explained by LVPWT, EDV, ESV, SV,
IVRT, LAV, e‘, a‘ and E/e‘, and 41.4% of ferritin lev-
els in SCD patients were explained by IVST,
LVPWT, EDV, ESV, IVRT, LAV, e‘, a‘ and E/e‘.Discussion
Tissue Doppler Imaging (TDI) is at the forefront
in the transthoracic echocardiographic assessmentof LVdiastolic function as it is less hindered by pre-
load dependency. Mitral valve annular velocities
can be used to draw inference about LV relaxation
and along with mitral peak E velocity (E/e‘ ratio)
can be used to predict LV filling pressure [21].
To the best of our knowledge, this study repre-
sents the first echocardiographic study evaluating
both LV systolic and diastolic function in patients
suffering from the Arab-Indian haplotype of SCD.
In this study, the LV internal dimensions, wall
thicknesses, volumes and mass indexes were sig-
nificantly increased in SCD patients, though the
LV ejection fraction was similar in both groups.
These cardiac abnormalities are really needed in
patients with chronic anemia to increase the car-
diac output with little increase in heart rate. How-
ever, we found that LV diastolic dysfunction is
common in the SCD patients. Our data showed
that 24% of SCD patients had lateral mitral annu-
lar ‘‘e‘/a‘ ratio <1’’ and in 24% there was evidence
of increased LV filling pressure with ‘‘E/e‘ ra-
tio > 8’’. These findings agree with earlier studies
of Doppler filling abnormalities,[15,23,24] though
the prevalence of LV diastolic dysfunction was
higher in our study than that observed by Schdev
V. et al., in spite of the lower mean age of our pa-
tients in comparison with the mean age in that
study (27.6 years vs. 35 years) [15]. In our opinion,
the moderate increase in E/e‘ ratio (between 8 and
15) as a predictor of increased LV filling pressure
and as a marker of LV diastolic dysfunction is
powered by the significant increase in the mean
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Figure 2. The difference between SCD patients and controls regarding the LV diastolic function parameters.
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ary hypertension in 40% of our SCD patients. The
prevalence of PH in our SCD patients agrees with
the earlier finding of Aleem A et al.[18] We believe
that LV diastolic dysfunction was not the only
hemodynamic confounder of the significant left
atrial dilatation in SCD patients, but may also
have been provoked by other factors such as
chronic anemia, chronic ischemia-perfusion injury
of the atrial walls, and possible iron overload sec-
ondary to recurrent hemolytic episodes [1,15].
Similarly, PH was more prevalent in our SCD
patients (40%) than LV diastolic dysfunction
(24%). This suggests that the LV diastolic dysfunc-
tion was not the only hemodynamic cause of PH.
Other factors such as chronic vasculopathy, recur-
rent pulmonary embolization, chronic ischemia-Figure 3. The prevalence pulmonary artery hypertension in SCD
patients.perfusion injury of the lungs, and the chronic high
output state associated with SCD also contribute
to the development of PH [25–32]. Nonetheless,
the exact mechanistic pathways of LV diastolic
dysfunction are still uncertain. Though, we are in
accord with the opinion that the diastolic dysfunc-
tion in SCD patients is mainly due to the recurrent
myocardial damage from vascular vaso-occlusive
disease and iron overload [15]. Finally, the occur-
rence of LV diastolic dysfunction and/or PH in
SCD patient may be considered an adverse prog-
nostic risk factor for increased mortality [15,32].Conclusion
Tissue Doppler Imaging (TDI) has become a
very important tool for the diagnosis of LV dia-
stolic function. Therefore, for adolescent and adult
patients with SCD, routine echocardiographic
studies should be performed as a part of their con-
tinuous medical care to identify high-risk patients
who may benefit from additional treatment.
Study limitations
The echocardiographic studies should be sup-
plemented with cardiac catheterization for confir-
mation of PH and pulmonary capillary wedge
pressure in high risk patients with SCD.Conflict of interest
Authors have no conflict of interest to declare.
Figure 4. Prevalence LV diastolic dysfunction (DD) among SCD patients and LV diastolic dysfunction when associated with pulmonary
hypertension.
FU
LL
 L
EN
G
TH
 A
RT
IC
LE
J Saudi Heart Assoc
2012;24:217–224
ABDUL-MOHSEN 223
ECHOCARDIOGRAPHIC EVALUATION OF LEFT VENTRICULAR DIASTOLIC AND SYSTOLIC FUNCTIONAcknowledgements
We would like to express our sincerest appreciation
to Dr. Ashok Upadhyaya, physician and echo-cardiog-
rapher of King Fahd Hospital of the University for his
Remarkable Effort in performing the echocardiographic
studies. We are also indebted to Dr. Hany Mowafi,
Associate Professor of Anaesthesia, and to Dr. Ammar
H. Khamis, Associate Professor of biostatistics, Univer-
sity of Dammam for their contribution in the statistical
analysis of this study. We would like also to appreciate
the effort of Mrs. Amgad Fakhry, Adel Fakhry and Mr.
Ramesh Kumar for secretarial assistance. Finally the
editorial review of this manuscript by Professor
E. Larbi, Professor of Medicine and Clinical Pharmacol-
ogy, is greatly appreciated.References
[1] Nagueh SF, Appleton CP, Gillebert TC, et al.
GUIDELINES and STANDARDS Recommendations for
the Evaluation of Left Ventricular Diastolic Function by
Echocardiography. J Am Soc Echocardiogr 2009;22(2):
107–33.
[2] Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle
cell disease Life expectancy and risk factors for early
death. N Engl J Med 1994;330:1639–44.
[3] AlHamdan NA, AlMazrou YY, AlSwaidi FM, Choudhry
AJ. Premarital screening for thalassemia and sickle cell
disease in Saudi Arabia. Genet Med 2007;9:372–7
[PubMed].
[4] Nasserullah Z, Alshammari A, Abbas MA, et al. Regional
experience with newborn screening for sickle cell disease,
other hemoglobinopathies and G6PD deficiency. Ann
Saudi Med 2003;23:354–7 [PUBMED].
[5] Nasserullah Z, Al Jame A, Abu Srair H, et al. Neonatal
screening for sickle cell disease, glucose-6-phosphate
dehydrogenase deficiency and a-thalassemia in Qatif and
Al Hassa. Ann Saudi Med 1998;18:289–92.
[6] El-Hazmi MA, Warsy AS, Al-Swailem AR, Al-Swailem
AM, Bahakim HM. Sickle cell gene in the population of
Saudi Arabia. Hemoglobin 1996;20:187–98.[7] Pagnier J, Mears JG, Belkhodja OD, et al. Evidence for the
multicentric origin of the sickle cell hemoglobin gene in
Africa. Proc Natl Acad Sci USA 1984;81:1771–3.
[8] Kulozik AE, Wainscoat JS, Serjeant GR, et al. Geographical
survey of b-globin gene haplotypes Evidence for an
independent Asian origin of the sickle cell mutation. Am
J Hum Genet 1986;39:239–44.
[9] Lapoumiroulie C, Dunda O, Ducrocq R, et al. A novel
sickle gene of yet another origin in Africa: The Cameroon
type. Hum Genet 1992;89:333–7.
[10] Serjeant GR, Serjeant BE. Sickle cell disease in Saudi
Arabia: The Asian haplotype: Reflections on a meeting
at Hofuf, September 2003. Ann Saudi Med 2004;24:
166–8.
[11] Pearson HA. Reply: Sickle cell disease in the Kingdom of
Saudi Arabia: East and West. Ann Saudi Med
1999;19:281–2.
[12] Zilberman MV, Wei Du, Das S, Sarnaik SA. Evaluation of
Left Ventricular Diastolic Function in Pediatric Sickle Cell
Disease Patients. Am J Hematol 2007;82:433–8.
[13] Batra AS, Acherman RJ, Wong W, et al. Cardiac
abnormalities in children with sickle cell anemia. A J
Hematol 2002;70:306–12.
[14] Lamers L, Ensing G, Pignatelli R, et al. Evaluation of left
ventricular systolic function in pediatric sickle cell patients
using the end-systolic wall stress-velocity of
circumferential fiber shortening relationship. J Am Coll
Cardiol 2007;49:472–9.
[15] Sachdev V, Machado RF, Shizukuda Y, et al. Diastolic
Dysfunction Is an Independent Risk Factor for Death in
Patients With Sickle Cell Disease. J Am Coll Cardiol
2007;49:472–9.
[16] Alabdulaali MK. Sickle cell disease patients in eastern
province of Saudi Arabia suffer less severe acute chest
syndrome than patients with African haplotypes. Ann
Thorac Med 2007;2(4):158–62.
[17] Jastaniah W. Epidemiology of sickle cell disease in Saudi
Arabia. Ann Saudi Med 2011;31(3):289–93.
[18] Aleem A, Jehangir A, Owais M, et al. Echocardiographic
abnormalities in adolescent and adult Saudi patients with
sickle cell disease. Saudi Med J 2007;28(7):1072–5.
[19] Devereux RB. Performance of primary and derived
M-mode echocardiographic measurements for detection
of left ventricular hypertrophy in necropsied subjects and
in patients with systemic hypertension, mitral
regurgitation, and dilated cardiomyopathy. Am J Cardiol
1986;57:450–5.
FU
LL LEN
G
TH
 A
RTIC
LE
224 ABDUL-MOHSEN
ECHOCARDIOGRAPHIC EVALUATION OF LEFT VENTRICULAR DIASTOLIC AND SYSTOLIC FUNCTION
J Saudi Heart Assoc
2012;24:217–224[20] Snider AR, Serwer GA, Ritter SB, editors.
Echocardiography in Pediatric Heart Disease. St.
Louis: Mosby; 1997. pp. 596.
[21] Rakowski H, Appleton C, Chan KL, et al. Canadian
consensus recommendations for the measurement and
reporting of diastolic dysfunction by echocardiography:
From the investigators of consensus on diastolic
dysfunction by echocardiography. J Am Soc Echocardiogr
1996;9:736–60.
[22] AlamM, Wardell J, Anderson E, Samad BA, Nordlander R.
Characteristics of mitral and tricuspid annular velocities
determined by pulsed wave Doppler tissue imaging in
healthy subjects. J Am Soc Echocardiogr 1999;12:
618–28.
[23] Balfour IC, Covitz W, Arensman FW, Eubig C, Garrido M,
Jones C. Left ventricular filling in sickle cell anemia. Am J
Cardiol 1988;61:395–9.
[24] Bella JN, Palmieri V, Roman MJ, et al. Mitral ratio of peak
early to late diastolic filling velocity as a predictor of
mortality in middle-aged and elderly adults: the Strong
Heart Study. Circulation 2002;105:1928–33.
[25] Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte
A, Saldana MJ. Pulmonary hypertension in sickle cellhemoglobinopathy: a clinicopathologic study of 20 cases.
Hum Pathol 2002;33:1037–43.
[26] Manci EA, Culberson DE, Yang YM, et al. Causes of death
in sickle cell disease: an autopsy study. Br J Haemato
2003;123:359–65.
[27] Perronne V, Roberts-HarewoodM, Bachir D, et al. Patterns
of mortality in sickle cell disease in adults in France and
England. Hematol J 2002;3:56–60.
[28] Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary
hypertension as a risk factor for death in patients with
sickle cell disease. N Engl J Med 2004;350:886–95.
[29] Castro O, Hoque M, Brown BD. Pulmonary hypertension
in sickle cell disease: cardiac catheterization results and
survival. Blood 2003;101:1257–61.
[30] Vichinsky EP. Pulmonary hypertension in sickle cell
disease. N Engl J Med 2004;350:857–9.
[31] Ataga KI, Moore CG, Jones S, et al. Pulmonary
hypertension in patients with sickle cell disease: a
longitudinal study. Br J Haematol 2006;134:109–15.
[32] Rodgers GP, Walker EC, Podgor MJ. Is ‘‘relative’’
hypertension a risk factor for vaso-occlusive
complications in sickle cell disease? Am J Med Sci
1993;305:150–6.
